1)  cetuximab
cetuximab
1.
In this article the pharmacokenetics and clinical study of 3 anti-EGFR monoclonal antibodies (cetuximab, panitumumab and nimotuzomab) were reviewed.
本文对3种抗EGFR单克隆抗体(cetuximab,panitumumab和nimotuzomab)的药代动力学及其应用研究进行了综述。
2)  cetuximab
西昔妥单抗
3)  Cetuximab
西妥昔单抗
1.
Evaluation of Cetuximab in combination with radiotherapy or chemotherapy against advanced squamous cell carcinoma of the head and neck;
西妥昔单抗联合化疗或放疗治疗晚期头颈鳞癌的疗效评价(英文)
2.
Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402;
西妥昔单抗联合厄洛替尼对人肝癌细胞的体外抑制作用
3.
Clinical observation of combination chemotherapy for metastatic colorectal cancer with Cetuximab;
西妥昔单抗联合化疗治疗转移性结直肠癌的临床观察
4)  Cetuximab(C225)
西妥昔单抗（C225）
5)  Cetuximab (C225)
cetuximab（C225）
6)  Rituximab
美罗华
1.
The Efficacy of Rituximab Combined with Chemotherapy in Treating Aggressive B-Cell Non-Hodgkin's Lymphoma;
美罗华联合化疗治疗侵袭性B细胞非霍奇金淋巴瘤的临床分析
2.
Evidence-Based Treatment of a Patient with Follicular Lymphoma by Rituximab;
美罗华在1例滤泡型淋巴瘤患者中的循证应用
3.
Combination of CHOP and Rituximab for B cell non-Hodgkin s lymphoma(six cases report);
CHOP+美罗华方案治疗B细胞非霍奇金淋巴瘤6例临床观察
参考词条
补充资料：昔留昔零
1.象声词。形容风雨等的飘打声。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。